Results 261 to 270 of about 38,246 (331)

<i>Erratum</i> to: Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

Barbara Gianesin, Frédéric B. Piel, Khaled M. Musallam, Susanna Barella, Maddalena Casale, Elena Cassinerio, Rosario Di Maggio, Antonia Gigante, Maria Rita Gamberini, Giovanna Graziadei, Roberto Lisi, Filomena Longo, Aurelio Maggio, Raffaella Origa, A Pasanisi, Silverio Perrotta, Antonio Piga, Valeria Maria Pinto, Rosamaria Rosso, Giacomo Robello, Giovanna Russo, Marco Zecca, Lucia De Franceschi, Gian Luca Forni   +23 more
openalex   +2 more sources

A 34-year-old man with tea-coloured urine. [PDF]

CMAJ
Barsanti-Innes B, Koda Y, Hsia CC, Chin-Yee B.   +3 more
europepmc   +1 more source

Paraspinal Extramedullary Haematopoiesis in A Patient with Sickle Cell Disease: A Rare Clinical Presentation. [PDF]

Eur J Case Rep Intern Med
Raje A, Siddi G, D'Souza A, Correa A.
europepmc   +1 more source

Prevalence of Hemoglobinopathies in Patients of Ischemic Stroke

Fariha Irfan, A. Tahir, Kanwal Mazhar
openalex   +2 more sources

Rheological aspects of sickle cell anemia and related hemoglobinopathies

, 1976
Freeman Elbert Self
openalex   +1 more source

Prevalence and Detection of Novel Thalassemia Variant hemoglobin J in Extensive Tharu Population.

Ann Afr Med
Nigam N, Gupta R, Bhatt MLB, Sinha S, Verma N, Nigam SK, Verma SP, Upadhyay K, Gupta S.   +8 more
europepmc   +1 more source

Hemoglobinopathies.

JPMA. The Journal of the Pakistan Medical Association, 1976
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Nature Medicine, 2022
Elisa Magrin, Nicolas Hebert, Alessandra Magnani   +2 more
exaly   +2 more sources

Impact of a transition program with navigator on loss to follow‐up, medication adherence, and appointment attendance in hemoglobinopathies

Pediatric Blood and Cancer, 2019
Transition from pediatric to adult care is a period of high risk for loss to follow‐up, morbidity, and mortality in adolescents and young adults (AYA) with hemoglobinopathies.
Brooke Allemang Msw, Rsw, Kate Allan, Msw, Melina Cheong   +2 more
exaly   +2 more sources